123 related articles for article (PubMed ID: 15448223)
1. Pulmonary function test as screening test for pulmonary artery hypertension in scleroderma patients.
Gupta R
Rheumatology (Oxford); 2004 Oct; 43(10):1315; author reply 1316. PubMed ID: 15448223
[No Abstract] [Full Text] [Related]
2. Screening for pulmonary arterial hypertension in systemic sclerosis.
Busteed S; Moots RJ; Thompson RN
Rheumatology (Oxford); 2004 Oct; 43(10):1315-6; author reply 1316. PubMed ID: 15448224
[No Abstract] [Full Text] [Related]
3. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
4. Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts?
Pamidi S; Mehta S
J Rheumatol; 2009 Feb; 36(2):216-8. PubMed ID: 19208554
[No Abstract] [Full Text] [Related]
5. Nonspecific interstitial pneumonia and systemic sclerosis.
King TE
Am J Respir Crit Care Med; 2002 Jun; 165(12):1578-9. PubMed ID: 12070054
[No Abstract] [Full Text] [Related]
6. Screening for pulmonary hypertension in scleroderma: how and when to look?
Mehta S; Little S
J Rheumatol; 2006 Feb; 33(2):204-6. PubMed ID: 16465647
[No Abstract] [Full Text] [Related]
7. P-wave amplitude and pulmonary artery pressure in scleroderma.
Wokhlu N; Hsu VM; Wilson A; Moreyra AE; Shindler D
J Electrocardiol; 2006 Oct; 39(4):385-8. PubMed ID: 16919671
[TBL] [Abstract][Full Text] [Related]
8. Screening and therapy of pulmonary hypertension in systemic sclerosis.
Bull TM
Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
Steen VD; Lucas M; Fertig N; Medsger TA
J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
[TBL] [Abstract][Full Text] [Related]
10. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of pulmonary artery hypertension and some functional parameters in obstructive bronchopulmonary disease].
Nikodýmová L; Ressl J; Jedlicka K; Widimský J
Vnitr Lek; 1978 Mar; 24(3):209-18. PubMed ID: 644890
[No Abstract] [Full Text] [Related]
12. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
Proudman SM; Stevens WM; Sahhar J; Celermajer D
Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
[TBL] [Abstract][Full Text] [Related]
13. Development of experimental pulmonary hypertension.
Herget J; Holusa R; Palecek F
Physiol Bohemoslov; 1974; 23(6):527-37. PubMed ID: 4280086
[No Abstract] [Full Text] [Related]
14. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR
J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis.
Ungerer RG; Tashkin DP; Furst D; Clements PJ; Gong H; Bein M; Smith JW; Roberts N; Cabeen W
Am J Med; 1983 Jul; 75(1):65-74. PubMed ID: 6859087
[TBL] [Abstract][Full Text] [Related]
16. Advancements in diagnosis of pulmonary arterial hypertension in scleroderma.
Steen V
Arthritis Rheum; 2005 Dec; 52(12):3698-700. PubMed ID: 16320319
[No Abstract] [Full Text] [Related]
17. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
18. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.
Fischer A; Bull TM; Steen VD
Arthritis Care Res (Hoboken); 2012 Mar; 64(3):303-10. PubMed ID: 22076819
[No Abstract] [Full Text] [Related]
19. The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension.
Mukerjee D; Yap LB; Ong V; Denton CP; Howells K; Black CM; Coghlan JG
Ann Rheum Dis; 2004 Dec; 63(12):1627-31. PubMed ID: 15547087
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary hypertension in patients with systemic sclerosis].
Ciurzyński M; Bienias P; Pruszczyk P
Kardiol Pol; 2007 Aug; 65(8):994-1000. PubMed ID: 17853323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
